Pharmafile Logo

Peter Impey

Waking the sleeping giant

The lights are coming on for healthcare delivery in Africa

- PMLiVE

AbbVie slumps on trial results for would-be blockbuster Rova-T

The pharma group saw its shares plummet after the news broke

- PMLiVE

Rubica appoints former GSK executive communications and engagement lead

Caroline Gosling becomes Rubica’s director of culture and engagement

- PMLiVE

Six new national standards are launched across UK

Will help to improve public involvement in research says ABPI’s Mike Thompson

- PMLiVE

Therachon poaches Shire’s Aled Williams

He becomes the biotech’s chief commercial officer and head of patient access

- PMLiVE

Sun Pharma passes milestone with novel psoriasis drug approval

Ilumya will treat adults with a moderate-to-severe form of the skin condition

Celgene building

Celgene bulks up pipeline again with $2.1bn Prothena deal

Acquires candidates with potential in Alzheimer’s, ALS and dementia

- PMLiVE

IMI calls for advancements in machine learning and digital clinical trials

Will reserve up to €82m for universities, SMEs and patient organisations

- PMLiVE

McCann Health promotes Briana Ferrigno to president of McCann Global Health

She will drive growth and diversification of the agency’s portfolio

- PMLiVE

Apitope strengthens its board with new director

Dr William Jenkins joins the board following a 30-year career in clinical medicine

Bayer looks to leverage AI across the pharma value chain

Dieter Weinand outlines his hopes for applying artificial intelligence

- PMLiVE

Seattle Genetics claims key US approval for Adcetris

Becomes the first new treatment for advanced Hl in more than 40 years

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links